Tenosynovial Giant Cell Tumor News and Research

RSS
FDA approves first therapy for symptomatic tenosynovial giant cell tumor

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Daiichi Sankyo, Plexxikon’s Phase 1 trial shows PLX3397 induced prolonged tumor regression in TGCT patients

Daiichi Sankyo, Plexxikon’s Phase 1 trial shows PLX3397 induced prolonged tumor regression in TGCT patients